A new trading day began on Monday, with Verrica Pharmaceuticals Inc (NASDAQ: VRCA) stock price down -3.76% from the previous day of trading, before settling in for the closing price of $0.70. VRCA’s price has ranged from $0.61 to $11.41 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -17.00%. Meanwhile, its annual earnings per share averaged 0.14%. With a float of $49.03 million, this company’s outstanding shares have now reached $90.56 million.
The extent of productivity of a business whose workforce counts for 100 workers is very important to gauge. In terms of profitability, gross margin is 72.9%, operating margin of -815.5%, and the pretax margin is -922.81%.
Verrica Pharmaceuticals Inc (VRCA) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Verrica Pharmaceuticals Inc is 45.86%, while institutional ownership is 15.82%. The most recent insider transaction that took place on Aug 26 ’24, was worth 69,647. In this transaction CHIEF LEGAL OFFICER of this company sold 26,183 shares at a rate of $2.66, taking the stock ownership to the 115,303 shares. Before that another transaction happened on Aug 27 ’24, when Company’s CHIEF LEGAL OFFICER sold 9,530 for $2.46, making the entire transaction worth $23,444. This insider now owns 105,773 shares in total.
Verrica Pharmaceuticals Inc (VRCA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 0.14% per share during the next fiscal year.
Verrica Pharmaceuticals Inc (NASDAQ: VRCA) Trading Performance Indicators
Here are Verrica Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.83, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -0.62 in one year’s time.
Technical Analysis of Verrica Pharmaceuticals Inc (VRCA)
The latest stats from [Verrica Pharmaceuticals Inc, VRCA] show that its last 5-days average volume of 0.78 million was superior to 0.65 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 59.42%. Additionally, its Average True Range was 0.09.
During the past 100 days, Verrica Pharmaceuticals Inc’s (VRCA) raw stochastic average was set at 1.31%, which indicates a significant decrease from 33.40% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.81% in the past 14 days, which was lower than the 162.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9719, while its 200-day Moving Average is $4.3827. Now, the first resistance to watch is $0.7051. This is followed by the second major resistance level at $0.7366. The third major resistance level sits at $0.7631. If the price goes on to break the first support level at $0.6471, it is likely to go to the next support level at $0.6206. The third support level lies at $0.5891 if the price breaches the second support level.
Verrica Pharmaceuticals Inc (NASDAQ: VRCA) Key Stats
With a market capitalization of 60.79 million, the company has a total of 45,601K Shares Outstanding. Currently, annual sales are 5,120 K while annual income is -67,000 K. The company’s previous quarter sales were 5,180 K while its latest quarter income was -17,190 K.
